Search

Showing 71 - 80 of 427 results.

404 - Page not found

404 Page not found The location may have changed Please double-check the web address, look for your topic via search or look at our sitemap.
Patients who benefit

A STATE-OF-THE-ART TREATMENT OPTION FOR PATIENTS AT HIGH RISK FOR SURGERY TriClip™ TEER is a low risk,5 minimally invasive, non-surgical treatment option for symptomatic patients with severe Tricuspi
Features

The TriClip™ G4 Transcatheter Edge-to-Edge Repair System empowers you with stable navigation and precise delivery2 for complex conditions.
Clinical Data

MitraClip™ + GDMT patients were more likely to be in NYHA functional class I or II throughout the 5 years MitraClip™ + GDMT patients benefited from a 47% relative risk reduction in HFH/ Death versu
Guidelines & Recommendations

Compelling data resulted in positive guidelines recommending PFO closure Long-term data from the both the RESPECT trial12 and REDUCE trial,13 as well as data from the CLOSE trial,14 have revealed tha
Therapy

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding LAA Occlusion HOW DOES IT WORK? SUPPORTED BY GUIDELINES, PROVEN BY DATA PROVEN R
Guidelines

2024 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPED IN COLLABORATION WITH THE EUROPEAN ASSOCIATION OF CARDIOTHORACIC SURGERY (EACTS)4-7 ACCESS TO
Guidelines & Recommendations

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding LAA Occlusion 2024 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGE
Patients who benefit

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding LAA Occlusion